Subconjunctival steroid in the management of uveal juvenile xanthogranuloma: a case report.
Uveal juvenile xanthogranuloma (JXG) is a rare intraocular tumor which usually occurs in very young children. Most reported cases of successfully treated uveal juvenile xanthogranuloma have received systemic steroids, irradiation or excision. Some cases have responded to topical steroids alone. We report a case of JXG with recurrent hyphemas and elevated intraocular pressures despite the use of topical steroid. This patient responded to the addition of subconjunctival steroid injection. This is the first report to our knowledge demonstrating a response to periocular steroid supplementation for uveal JXG unresponsive to topical steroids.
Treacy
K W
KW
Department of Ophthalmology, University of Minnesota, Minneapolis.
Letson
R D
RD
Summers
C G
CG
D001623:Betamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D003228:Conjunctiva; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006988:Hyphema / Q000150:complications / Q000188:drug therapy; D007223:Infant; D007267:Injections; D007429:Intraocular Pressure / Q000187:drug effects; D007499:Iris Diseases / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D014972:Xanthogranuloma, Juvenile / Q000150:complications / Q000188:drug therapy*
D003907:Dexamethasone; D001623:Betamethasone; D011239:Prednisolone